top of page

Sutro Biopharma is developing next generation antibody-drug conjugates, including dual payload ADCs. CEO Jane Chung walks us through their programs

  • May 20
  • 1 min read

She describes a dual payload ADC targeting TROP2 that is partnered with Astellas, as well as internal programs targeting tissue factor (currently in the clinic), integrin β6, and a dual payload ADC targeting PTK7.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page